193 related articles for article (PubMed ID: 19666870)
1. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.
Cheng K; Sportoletti P; Ito K; Clohessy JG; Teruya-Feldstein J; Kutok JL; Pandolfi PP
Blood; 2010 Apr; 115(16):3341-5. PubMed ID: 19666870
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
3. Expression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.
Bolli N; Payne EM; Grabher C; Lee JS; Johnston AB; Falini B; Kanki JP; Look AT
Blood; 2010 Apr; 115(16):3329-40. PubMed ID: 20197555
[TBL] [Abstract][Full Text] [Related]
4. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.
den Besten W; Kuo ML; Williams RT; Sherr CJ
Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118
[TBL] [Abstract][Full Text] [Related]
5. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
[TBL] [Abstract][Full Text] [Related]
6. Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.
Cilloni D; Messa F; Rosso V; Arruga F; Defilippi I; Carturan S; Catalano R; Pautasso M; Panuzzo C; Nicoli P; Messa E; Morotti A; Iacobucci I; Martinelli G; Bracco E; Saglio G
Leukemia; 2008 Jun; 22(6):1234-40. PubMed ID: 18401421
[TBL] [Abstract][Full Text] [Related]
7. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
[TBL] [Abstract][Full Text] [Related]
8. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies against nucleophosmin mutants: potentials for the detection of acute myeloid leukemia.
Tan S; Zhang L; Zhong XM; Yang ZL; Zhao LY; Gao YJ; Shao HY; Qin FX; Chen XC; Zhang HJ; Chen H; Wang L
Int J Med Sci; 2011; 8(4):309-14. PubMed ID: 21611112
[TBL] [Abstract][Full Text] [Related]
11. Selective Toxicity of Investigational Ixazomib for Human Leukemia Cells Expressing Mutant Cytoplasmic NPM1: Role of Reactive Oxygen Species.
Garcia JS; Huang M; Medeiros BC; Mitchell BS
Clin Cancer Res; 2016 Apr; 22(8):1978-88. PubMed ID: 26634271
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
13. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.
Rau R; Brown P
Hematol Oncol; 2009 Dec; 27(4):171-81. PubMed ID: 19569254
[TBL] [Abstract][Full Text] [Related]
14. The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model.
Sportoletti P; Varasano E; Rossi R; Bereshchenko O; Cecchini D; Gionfriddo I; Bolli N; Tiacci E; Intermesoli T; Zanghì P; Masciulli A; Martelli MP; Falzetti F; Martelli MF; Falini B
Blood; 2013 Apr; 121(17):3447-58. PubMed ID: 23435463
[TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis.
Konoplev S; Huang X; Drabkin HA; Koeppen H; Jones D; Kantarjian HM; Garcia-Manero G; Chen W; Medeiros LJ; Bueso-Ramos CE
Cancer; 2009 Oct; 115(20):4737-44. PubMed ID: 19637342
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation.
Tripodo C; Bassani B; Jachetti E; Cancila V; Chiodoni C; Portararo P; Botti L; Valenti C; Perrone M; Ponzoni M; Comoli P; Lecchi M; Verderio P; Curti A; Colombo MP; Sangaletti S
Elife; 2022 Apr; 11():. PubMed ID: 35471185
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
19. The incidence and clinical significance of nucleophosmin mutations in childhood AML.
Brown P; McIntyre E; Rau R; Meshinchi S; Lacayo N; Dahl G; Alonzo TA; Chang M; Arceci RJ; Small D
Blood; 2007 Aug; 110(3):979-85. PubMed ID: 17440048
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
Falini B; Nicoletti I; Martelli MF; Mecucci C
Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
